Bilateral panuveitis in Whipple's disease: Case report

被引:1
作者
Loiseau, V. [1 ]
Chopin, M. -c. [2 ]
Antoine, P. [3 ]
Landrieux, M. [4 ]
Moritz, F. [4 ]
机构
[1] CHU Lille, Hop Claude Huriez, Serv Ophtalmol, Rue Michel Polonowski, F-59000 Lille, France
[2] Ctr Hosp Boulogne Sur Mer, Serv Malad Infecti & Trop, Rue Jacques Monod, F-62200 Boulogne Sur Mer, France
[3] Ctr Hosp Boulogne Sur Mer, Serv Nephrol Med Interne, Rue Jacques Monod, F-62200 Boulogne Sur Mer, France
[4] Ctr Hosp Boulogne Sur Mer, Serv Ophtalmol, Rue Jacques Monod, F-62200 Boulogne Sur Mer, France
来源
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2024年 / 47卷 / 08期
关键词
Inflammation; Uveitis; Whipple's disease; Vasculitis; Retinitis; TROPHERYMA-WHIPPLEI;
D O I
10.1016/j.jfo.2024.104262
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Whipple's disease is a rare disease linked to chronic infection with the intracellular gram-positive bacterium, Tropheryma whipplei. The clinical signs suggestive of this disease are the association of unexplained fever, lymphadenopathy, gastroenterological disorders (malabsorption) and inflammatory joint disorders (arthritis). However, isolated cardiological, neurological or ophthalmological forms have been described. We report the rare case of a 56- year-old patient complaining of floaters and recent visual loss, who presented with bilateral panuveitis in the absence of any systemic disorder. Clinical examination showed inflammation of the anterior segment, vitritis, inflammatory optic disc edema, focal retinitis, and venous vasculitis in both eyes. We describe the clinical characteristics and ancillary findings of the disease (fundus photos, visual field, auto-fluorescence, macular OCT, fluorescein and indocyanine green angiography). The diagnosis was made with the blood (T. whipplei) PCR test and with the help of accessory salivary gland biopsies. We describe the work-up leading to the diagnosis of Whipple's disease, the laboratory tests, and the recommended extended work-up. The patient's course was marked by complete resolution of the symptoms and clinical signs within a few months following corticosteroid therapy (1 mg/kg/day) combined with hydroxychloroquine (600 mg per day for 1 year) and life-long doxycycline therapy (200 mg per day). In conclusion, this is a rare disease which should be discussed when dealing with steroid-resistant and/or steroid-dependent chronic uveitis with a negative work-up (especially in the presence of joint and/or digestive involvement). (c) 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页数:8
相关论文
共 17 条
[1]  
Arriola-Villalobos P, 2016, MED CLIN-BARCELONA, V146, P467, DOI 10.1016/j.medcli.2015.11.020
[2]   Unique Features of Posterior Ocular Involvement of Whipple's Disease in a Patient with No Gastrointestinal Symptoms [J].
Bosello, Francesca ;
Casalino, Giuseppe ;
Neri, Enrico ;
Alfano, Alessandro ;
Bonora, Adriana ;
Marchini, Giorgio .
OCULAR IMMUNOLOGY AND INFLAMMATION, 2022, 30 (05) :1168-1171
[3]   Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells [J].
Boulos, A ;
Rolain, JM ;
Raoult, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (03) :747-752
[4]   Ocular Whipple's disease - Earlier definitive diagnosis [J].
Chan, RY ;
Yannuzzi, LA ;
Foster, CS .
OPHTHALMOLOGY, 2001, 108 (12) :2225-2231
[5]  
Cunningham S, 2015, Rev Med Suisse, V484, P1582
[6]   Clinical Manifestations, Treatment, and Diagnosis of Tropheryma whipplei Infections [J].
Dolmans, Ruben A. V. ;
Boel, C. H. Edwin ;
Lacle, Miangela M. ;
Kusters, Johannes G. .
CLINICAL MICROBIOLOGY REVIEWS, 2017, 30 (02) :529-555
[7]   Whipple disease - Clinical review of 52 cases [J].
Durand, DV ;
Lecomte, C ;
Cathebras, P ;
Rousset, H ;
Godeau, P ;
Boucher, JP ;
Simon, G ;
Dupond, JL ;
Miguet, JP ;
deWazieres, B ;
Chraibi, A ;
Dabadie, H ;
Paccalin, J ;
Bocquet, B ;
Bruhiere, J ;
Debat, P ;
Philippe, P ;
Devaux, P ;
Adam, G ;
Hillon, P ;
Massot, P ;
Cance, P ;
Waton, M ;
Levrat, R ;
Pasquier, J ;
Trepo, C ;
Falconnet, M ;
Pauchard, J ;
Gutknecht, J ;
Janbon, C ;
Barrier, JH ;
Cottin, S ;
Guillon, J ;
MagadurJoly, G ;
Allard, C ;
Dessauw, P ;
Barbier, JP ;
Bleibel, JM ;
Buge, A ;
Cabane, J ;
Haas, C ;
Huguier, M ;
Piette, AM ;
Poisson, M ;
Wechsler, B ;
Grosbois, B ;
Audigier, JC ;
Mallet, H ;
Rouhier, D ;
Rondot, P .
MEDICINE, 1997, 76 (03) :170-184
[8]   Tropheryma whipplei natural resistance to trimethoprim and sulphonamides in vitro [J].
Fenollar, Florence ;
Perreal, Celine ;
Raoult, Didier .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (04) :388-390
[9]   Medical progress - Whipple's disease [J].
Fenollar, Florence ;
Puechal, Xavier ;
Raoult, Didier .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (01) :55-66
[10]   Survival of Tropheryma whipplei, the agent of Whipple's disease, requires phagosome acidification [J].
Ghigo, E ;
Capo, C ;
Aurouze, M ;
Tung, CH ;
Gorvel, JP ;
Raoult, D ;
Mege, JL .
INFECTION AND IMMUNITY, 2002, 70 (03) :1501-1506